Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/1998
11/10/1998US5834005 Implantable drug delivery capsules; polyxylylene membrane
11/10/1998US5834003 Topically applying chlorine dioxide activated and stabilized by a sodium phosphate; bactericides; fungicides; viricides
11/10/1998US5834002 Water insoluble gum base with water soluble bulk portion, flavors, colloidal bismuth salts of hydroxy carboxylic aicds, for treating helicobacter pylori infections, antiulcer agents
11/10/1998US5834001 Methods for making immunoisolatory implantable vehicles with a biocompatiable jacket and a biocompatible matrix core
11/10/1998US5833969 Aqueous cosmetic composition containing stably solubilized uric acid and amphoteric surfactant and method for stably solubilizing uric acid in aqueous cosmetic composition
11/10/1998US5833967 Colloidal silica as a reinforcing agent of keratin substances
11/10/1998US5833954 Anti-carious chewing gums, candies, gels, toothpastes and dentifrices
11/10/1998US5833950 Particle size control, fluorocarbon propellant
11/10/1998US5833891 Using high frequency sonic waves for breaking up fluid dispersion into extremely smalll droplets
11/10/1998US5833647 Mixing drug within gel with magnetic dipoles, applying oscillating magnetic field to agitate magnetic dipoles
11/10/1998CA2161697C Method and means for inhibiting posterior capsule opacification
11/05/1998WO1998049350A1 In vivo use of recombinagenic oligonucleobases to correct genetic lesions in hepatocytes
11/05/1998WO1998049202A1 NOVEL HETERO-POLYSACCHARIDE CONJUGATES, NOVEL s-INP POLYSACCHARIDE GELS AND METHODS OF MAKING AND USING THE SAME
11/05/1998WO1998049191A1 Novel pulmonary surfactants and therapeutic uses, including pulmonary lavage
11/05/1998WO1998049175A1 Method for producing carbohydrate partial esters
11/05/1998WO1998049162A1 Sulfonamides for treatment of endothelin-mediated disorders
11/05/1998WO1998049135A1 Compounds and compositions for delivering active agents
11/05/1998WO1998049134A1 Solid compositions suitable for oral administration comprising l-carnitine or alkanoyl-l-carnitine magnesium fumarate
11/05/1998WO1998048875A1 Method of delivering halotherapy
11/05/1998WO1998048873A1 Device for administering insulin in controlled dosages by controlling total inhaled volume
11/05/1998WO1998048839A1 Topical nasal antiinflammatory compositions
11/05/1998WO1998048821A2 Use of conantokins for producing analgesia or for neuroprotection
11/05/1998WO1998048814A1 Pourable alginate compositions
11/05/1998WO1998048803A1 Eyedrops
11/05/1998WO1998048783A1 Microparticles useful as ultrasonic contrast agents and for delivery of drugs into the bloodstream
11/05/1998WO1998048782A1 Method for producing orally administered, solid pharmaceutical products with controlled release of the active substance
11/05/1998WO1998048781A1 Controlled release of drugs delivered by sublingual or buccal administration
11/05/1998WO1998048780A1 Vesicular complexes and methods of making and using the same
11/05/1998WO1998048779A1 Emulsion preconcentrate comprising a cyclosporin and acetylated monoglyceride
11/05/1998WO1998048775A1 Serine protease and topical retinoid compositions
11/05/1998WO1998048723A1 Techniques for treating neurodegenerative disorders by infusion of nerve growth factors into the brain
11/05/1998WO1998048629A1 Non-spherical and non-platelet pyrithione salts
11/05/1998WO1998048621A1 Methods for viral inactivation and compositions for use in same
11/05/1998WO1998043618A3 Use of cytoskeletal inhibitors for the prevention of restenosis
11/05/1998WO1998042312A3 Medicament having sclerosing activity
11/05/1998WO1998034596A3 Biocompatible compounds for pharmaceutical drug delivery systems
11/05/1998CA2815903A1 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis
11/05/1998CA2291056A1 Non-spherical and non-platelet pyrithione salts
11/05/1998CA2288346A1 Use of conantokins for producing analgesia or for neuroprotection
11/05/1998CA2288257A1 Method of delivering halotherapy
11/05/1998CA2288209A1 In vivo use of recombinagenic oligonucleobases to correct genetic lesions in hepatocytes
11/05/1998CA2288138A1 Compounds and compositions for delivering active agents
11/05/1998CA2285983A1 Emulsion preconcentrate comprising a cyclosporin and acetylated monoglyceride
11/05/1998CA2281789A1 Topical nasal antiinflammatory compositions
11/05/1998CA2280747A1 Serine protease and topical retinoid compositions
11/04/1998EP0875253A2 Chondroitinase compositions
11/04/1998EP0875251A1 Therapeutic agent and method for feline aids virus infections and feline atopic dermatitis
11/04/1998EP0875248A1 Use of hyaluronic acid for the preparation of an aqueous solution useful as intra-articular lavage liquid
11/04/1998EP0875245A2 Substained release polymer blend matrix for pharmaceutical application
11/04/1998EP0875244A2 Cosmetically accceptable microstructured compositions
11/04/1998EP0874990A1 Storage-stable particle, in particular carrier for carrier-bound reactions, and methods of producing said particle
11/04/1998EP0874910A1 Peptide-enhanced cationic lipid transfections
11/04/1998EP0874765A1 Improved storage wrap material
11/04/1998EP0874685A1 Water-redispersible granules including a liquid active material and a non-ionic alkoxyl-type surfactant
11/04/1998EP0874643A2 Bioresponsive pharmacologically-active polymers and articles made therefrom
11/04/1998EP0874642A1 Sustained release drug formulations
11/04/1998EP0874640A1 Cyclosporin formulation
11/04/1998EP0874632A1 High-content famciclovir tablets
11/04/1998EP0874631A1 Use of valaciclovir for the manufacture of a medicament for the treatment of genital herpes by a single daily application
11/04/1998EP0874623A2 Water activatable adhesive matrix containing amethocaine
11/04/1998EP0874622A1 Pge-1 containing lyophilized liposomes for use in the treatment of erectile dysfunction
11/04/1998EP0874621A1 Pharmaceutical compositions
11/04/1998EP0874609A1 Therapeutic medical garments for scars and process
11/04/1998EP0874558A1 Liquid oral compositions comprising a calcium compound and an acidulant
11/04/1998EP0765158B1 Active substance carrier for the controlled release of active substances in the gastro-intestinal tract with delayed passage through the pylorus
11/04/1998EP0710104B1 Pharmaceutical compositions for hardly soluble active substances
11/04/1998EP0625901B1 Copolymer-based films, applications thereof in transdermal systems and processes for their preparation
11/04/1998EP0619802B1 A mixture of higher primary aliphatic alcohols and its pharmaceutical uses
11/04/1998EP0552227B2 Orally administered solvent-free pharmaceutical preparation with delayed active-substance release, and a method of preparing the preparation
11/04/1998CN1198104A Polyvinyl alcohol-based magnetic polymer particles, method for their preparation and their use
11/04/1998CN1198100A Chitosan drug delivery system
11/04/1998CN1198094A Solid medicaments obtained by extrusion of isomalt-containing polymer-active substance melt
11/04/1998CN1198093A Hormone replacement therapy method and hormone dispenser
11/04/1998CN1198091A Intravaginal rings with insertable drug-containing core
11/04/1998CN1197655A Smoking-giving up plaster and its preparation
11/04/1998CN1197654A Cardio- and cerebro-angiopathy curing drop pellet and its preparation
11/04/1998CN1197647A Hepatitis B virus resisting injection
11/04/1998CN1197644A Medicine for psoriasis
11/04/1998CN1197643A Wound ointment
11/04/1998CN1197639A Rapamycin formulations for oral administration
11/04/1998CN1197637A Delayed Pyquiton and its preparation
11/04/1998CN1197636A Freezing-dried tetracaine hydrochloride powder injection
11/04/1998CN1197635A Chinese medicine film and its preparation
11/03/1998US5830913 Method for preventing or treating dry eye or disease caused therefrom
11/03/1998US5830907 Application of riluzole in the treatment of neurological lesions associated with trauma
11/03/1998US5830887 Cancer, pms, menopause and hypercholesterolemia
11/03/1998US5830884 Pharmaceutical products containing thermally-inhibited starches
11/03/1998US5830883 Methods of creating a unique chitosan and employing the same to form complexes with drugs, delivery of the same within a patient and a related dosage form
11/03/1998US5830882 Compositions containing a form of hyaluronic acid and a medicinal agent for treating acne in mammals and methods for administration of such composition
11/03/1998US5830880 Gene therapy of tumors with an endothelial cell-specific, cell cycle-dependent active compound
11/03/1998US5830878 1,2-bis(2-oleoyloxy)ethyl)-3-(2-hydroxyethyl)imidazolinium chloride
11/03/1998US5830877 Method, compositions and devices for administration of naked polynucleotides which encode antigens and immunostimulatory
11/03/1998US5830865 Modified tripeptide stabilizer
11/03/1998US5830853 Administering insulin and absorption enhancer using a dry powder inhaler
11/03/1998US5830686 Gene expression
11/03/1998US5830576 Mixture of fine particles, nitrogen compound, microcrystalline cellulose and hydrocolloids
11/03/1998US5830546 Reservoir system for prolonged diffusion of an active principle
11/03/1998US5830509 Microparticle complexes with 2-amino-1-phenylpropanol materials
11/03/1998US5830508 Composition for treating dry eye
11/03/1998US5830507 Biotherapeutic cell-coated microspheres
1 ... 2576 2577 2578 2579 2580 2581 2582 2583 2584 2585 2586 2587 2588 2589 2590 2591 2592 2593 2594 2595 2596 ... 2991